Value of a cure for sickle cell disease in reducing economic disparities.
作者信息
Graf Marlon, Tuly Rifat, Gallagher Meghan, Sullivan Jeff, Jena Anupam Bapu
机构信息
PRECISIONheor, Bethesda, Maryland, USA.
Bluebird Bio, Inc., Cambridge, Massachusetts, USA.
出版信息
Am J Hematol. 2022 Aug;97(8):E289-E291. doi: 10.1002/ajh.26617. Epub 2022 Jun 6.
Abstract
摘要
相似文献
1
Value of a cure for sickle cell disease in reducing economic disparities.
Am J Hematol. 2022 Aug;97(8):E289-E291. doi: 10.1002/ajh.26617. Epub 2022 Jun 6.
2
Sickle cell disease: Status with particular reference to India.
Indian J Med Res. 2016 Jun;143(6):675-677. doi: 10.4103/0971-5916.191916.
3
Addressing bias towards patients with sickle cell disease.
Lancet Haematol. 2020 Jul;7(7):e508. doi: 10.1016/S2352-3026(20)30183-6.
4
Closing the Equity Gap: Early Intervention in Sickle Cell Disease.
Pediatrics. 2024 Jul 1;154(1). doi: 10.1542/peds.2023-065090.
5
Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia.
Hematol Oncol Clin North Am. 2004 Dec;18(6):1339-54, ix. doi: 10.1016/j.hoc.2004.07.004.
6
[Sickle cell anemia--old disease, new patients].
Harefuah. 2007 May;146(5):335-6, 408.
7
[Sickle-cell anemia: an emerging disease in Spain].
An Pediatr (Barc). 2003 Feb;58(2):93-4. doi: 10.1016/s1695-4033(03)78010-2.
8
Sickle cell disease in Africa.
Curr Opin Hematol. 2002 Mar;9(2):111-6. doi: 10.1097/00062752-200203000-00005.
9
World Sickle Cell Day 2016 : A time for appraisal.
Indian J Med Res. 2016 Jun;143(6):678-681. doi: 10.4103/0971-5916.191917.
10
Sickle cell disease.
Nat Rev Dis Primers. 2018 Mar 15;4:18011. doi: 10.1038/nrdp.2018.11.
引用本文的文献
1
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
Pharmacoeconomics. 2024 Jun;42(6):693-714. doi: 10.1007/s40273-024-01385-9. Epub 2024 Apr 29.
本文引用的文献
1
Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.
JAMA Netw Open. 2019 Nov 1;2(11):e1915374. doi: 10.1001/jamanetworkopen.2019.15374.
2
Predictors of Academic Achievement for School Age Children with Sickle Cell Disease.
Adv Sch Ment Health Promot. 2013;6(1):5-20. doi: 10.1080/1754730X.2012.760919. Epub 2013 Jan 25.
3
Health status and healthcare use in a national sample of children with sickle cell disease.
Am J Prev Med. 2010 Apr;38(4 Suppl):S528-35. doi: 10.1016/j.amepre.2010.01.003.
4
Mortality in sickle cell disease. Life expectancy and risk factors for early death.
N Engl J Med. 1994 Jun 9;330(23):1639-44. doi: 10.1056/NEJM199406093302303.
Zotero 插件